Chief Commercial Officer Edward Hensley had the opportunity to highlight the necessity of prioritizing patients’ and healthcare providers’ unique needs, especially in times of crisis, in Pharmaceutical Commerce.
His article, “Elevating brand outreach in the age of Covid,” explores how tech-enabled solutions facilitate processes, drive cost savings and deliver better patient outcomes to build brand loyalty long after a crisis has ended.
Read more in Pharmaceutical Commerce, a publication for biopharma commercial executive decision-makers focusing on business processes and the technologies involved in how approved drugs go to market.